(Q53109465)

11 May 2018

title

Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era. (English)

1 reference

11 May 2018

author

Andrew M Evens

1

1 reference

11 May 2018

Bruce Barton

9

1 reference

11 May 2018

Leo Gordon

10

1 reference

11 May 2018

Ralf Trappe

15

1 reference

11 May 2018

author name string

S Choquet

2

1 reference

11 May 2018

A R Kroll-Desrosiers

3

1 reference

11 May 2018

D Jagadeesh

4

1 reference

11 May 2018

S M Smith

5

1 reference

11 May 2018

F Morschhauser

6

1 reference

11 May 2018

V Leblond

7

1 reference

11 May 2018

R Roy

8

1 reference

11 May 2018

M K Gandhi

11

1 reference

11 May 2018

D Dierickx

12

1 reference

11 May 2018

D Schiff

13

1 reference

11 May 2018

T M Habermann

14

1 reference

11 May 2018

language of work or name

English

0 references

publication date

1 June 2013

1 reference

11 May 2018

American Journal of Transplantation

published in

1 reference

11 May 2018

volume

13

1 reference

11 May 2018

issue

6

1 reference

11 May 2018

page(s)

1512-1522

1 reference

11 May 2018

Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

cites work

1 reference

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

21 January 2018

1 reference

Posttransplant lymphoproliferative disorder: significance of central nervous system involvement

21 January 2018

1 reference

Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report

21 January 2018

1 reference

Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

21 January 2018

1 reference

Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.

21 January 2018

1 reference

Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate.

21 January 2018

1 reference

Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era.

21 January 2018

1 reference

Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.

21 January 2018

1 reference

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

21 January 2018

1 reference

Treatment for primary CNS lymphoma: the next step

21 January 2018

1 reference

Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.

21 January 2018

1 reference

Treatment of PTLD with rituximab or chemotherapy

21 January 2018

1 reference

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

21 January 2018

1 reference

Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

21 January 2018

1 reference

Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?

21 January 2018

1 reference

Surveillance of Epstein-Barr virus loads in adult liver transplantation: associations with age, sex, posttransplant times, and transplant indications.

21 January 2018

1 reference

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

21 January 2018

1 reference

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse

21 January 2018

1 reference

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

21 January 2018

1 reference

Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(★).

21 January 2018

1 reference

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

21 January 2018

1 reference

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

21 January 2018

1 reference

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

21 January 2018

1 reference

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience

21 January 2018

1 reference

Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates

21 January 2018

1 reference

Lymphomas occurring late after solid-organ transplantation

21 January 2018

1 reference

Identification of prognostic factors in post-transplant lymphoproliferative disorders

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AJT.12211

1 reference

11 May 2018

1 reference

11 May 2018